Early Market Access for Pharmaceuticals in EU- What is the Impact of Ema’s Accelerated Assessment Procedure?
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.710
https://www.valueinhealthjournal.com/article/S1098-3015(16)32076-9/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
673
First Page :
A469
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32076-9&doi=10.1016/j.jval.2016.09.710